Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)

SHE:002872 Revenue

In the year 2025, Tiansheng Pharmaceutical Group had annual revenue of 514.09M CNY, down -9.76%. Tiansheng Pharmaceutical Group had revenue of 165.28M in the quarter ending December 31, 2025, a decrease of -1.24%.

• Revenue: 514.09M
• Revenue Growth: -9.76%
• P/S Ratio: 3.37
• Revenue / Employee: 404.16K
• Employees: 1,272
• Market Cap: 1.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	514.09M	-55.63M	-9.76%
Dec 31, 2024	569.71M	-9.62M	-1.66%
Dec 31, 2023	579.33M	-27.66M	-4.56%
Jan 1, 2023	606.99M	-129.69M	-17.61%
Jan 1, 2022	736.69M	-466.06M	-38.75%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error